215 related articles for article (PubMed ID: 24581810)
1. Pre-operative MR evaluation of features that indicate the need of adjuvant therapies in early stage cervical cancer patients. A single-centre experience.
Rizzo S; Calareso G; Maccagnoni S; Angileri SA; Landoni F; Raimondi S; Pasquali E; Lazzari R; Bellomi M
Eur J Radiol; 2014 May; 83(5):858-64. PubMed ID: 24581810
[TBL] [Abstract][Full Text] [Related]
2. Prediction model of pelvic lymph node metastasis in early stage cervical cancer and its clinical value.
Sun JR; Zhang YN; Sun XM; Feng SY; Yan M
Minerva Chir; 2011 Dec; 66(6):537-45. PubMed ID: 22233660
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
4. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
5. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
6. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
[TBL] [Abstract][Full Text] [Related]
8. Preoperative prediction of lymph node metastasis and deep stromal invasion in women with invasive cervical cancer: prospective multicenter study using 2D and 3D ultrasound.
Pálsdóttir K; Fischerova D; Franchi D; Testa A; Di Legge A; Epstein E
Ultrasound Obstet Gynecol; 2015 Apr; 45(4):470-5. PubMed ID: 25092154
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of lymph node metastasis in uterine cervical cancer: usefulness of computer-aided diagnosis with comprehensive evaluation of MR images and clinical findings.
Kim MH; Kim JK; Lee Y; Park BW; Lee CK; Kim N; Cho G; Choi HJ; Cho KS
Acta Radiol; 2011 Dec; 52(10):1175-83. PubMed ID: 21969698
[TBL] [Abstract][Full Text] [Related]
10. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
[TBL] [Abstract][Full Text] [Related]
11. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
13. What is the risk for parametrial involvement in women with early-stage cervical cancer with tumour <20 mm and with negative sentinel lymph nodes?
Klat J; Sevcik L; Simetka O; Graf P; Dvorackova J; Kraft O
Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):540-4. PubMed ID: 23216324
[TBL] [Abstract][Full Text] [Related]
14. The value of 3.0Tesla diffusion-weighted MRI for pelvic nodal staging in patients with early stage cervical cancer.
Klerkx WM; Veldhuis WB; Spijkerboer AM; van den Bosch MA; Mali WP; Heintz AP; Bipat S; Sie-Go DM; van der Velden J; Schreuder HW; Stoker J; Peeters PH
Eur J Cancer; 2012 Dec; 48(18):3414-21. PubMed ID: 22835781
[TBL] [Abstract][Full Text] [Related]
15. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
[TBL] [Abstract][Full Text] [Related]
16. Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging.
Kim SH; Kim SC; Choi BI; Han MC
Radiology; 1994 Mar; 190(3):807-11. PubMed ID: 8115631
[TBL] [Abstract][Full Text] [Related]
17. Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation?
Ferrandina G; Fanfani F; Ludovisi M; Fagotti A; Carbone A; Zannoni G; Guerriero M; Petrillo M; Scambia G
Gynecol Oncol; 2008 Jan; 108(1):220-5. PubMed ID: 17976708
[TBL] [Abstract][Full Text] [Related]
18. Clinical staging and histopathological findings after radical hysterectomy in FIGO stage IIB cervical cancer.
Mandic A; Novakovic P; Mihajlovic O; Stojiljkovic B; Rajovic J; Davidovic M
J BUON; 2008; 13(1):51-4. PubMed ID: 18404786
[TBL] [Abstract][Full Text] [Related]
19. Can preoperative MRI accurately evaluate nodal and parametrial invasion in early stage cervical cancer?
Chung HH; Kang SB; Cho JY; Kim JW; Park NH; Song YS; Kim SH; Lee HP
Jpn J Clin Oncol; 2007 May; 37(5):370-5. PubMed ID: 17556538
[TBL] [Abstract][Full Text] [Related]
20. Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients?
Scambia G; Ferrandina G; Distefano M; Fagotti A; Manfredi R; Zannoni GF; Mancuso S
Gynecol Oncol; 2001 Nov; 83(2):319-24. PubMed ID: 11606092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
